Where Do We Stand? Insight on Patented Products and Those Under Clinical Trials Publisher



Lashgari NA^{1, 2} ; Roudsari NM^{1, 2} ; Shamsnia HS^{1, 2} ; Koolivand Z¹ ; Momtaz S^{3, 4} ; Abdolghaffari AH^{1, 2} ; Jamialahmadi T⁵ ; Kesharwani P⁶ ; Sahebkar A^{5, 7, 8} Show Affiliations
Source: Advances in Antiparasitic Therapies and Drug Delivery Published:2023

Abstract

There are many different reasons that motivate the scientific community to discover new drugs. From the industrial point of view, drugs with high absorption, potent effect, long half-life, and bioavailability are more important. Moreover, the cost of drug production and consumption has been considered very much. In addition to infectious diseases, the resistance to existing treatments makes the need for novel drugs even more important. Unfortunately, many pathogenic strains do not respond to the current treatments and other mechanisms should be used to eliminate them. For this reason, today, efforts are being made to find drugs with long-lasting potency, besides lower cost and side effects. Efforts in this field are always ongoing, as testified by the introduction of various newer drugs. The purpose of this chapter is to provide a perspective of antiparasitic drugs and their future. Data were collected from experimental and clinical studies in English from Google Scholar, PubMed, Scopus, and the Cochrane library. © 2024 Elsevier Inc. All rights reserved.